These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19548885)

  • 61. Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants.
    Pons MJ; Mensa L; Gascón J; Ruiz J
    Microb Drug Resist; 2012 Aug; 18(4):376-9. PubMed ID: 21711150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis.
    Takiff HE; Cimino M; Musso MC; Weisbrod T; Martinez R; Delgado MB; Salazar L; Bloom BR; Jacobs WR
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):362-6. PubMed ID: 8552639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fluoroquinolone-resistant Escherichia coli, Indonesia.
    Kuntaman K; Lestari ES; Severin JA; Kershof IM; Mertaniasih NM; Purwanta M; Hadi U; Johnson JR; van Belkum A; Verbrugh HA;
    Emerg Infect Dis; 2005 Sep; 11(9):1363-9. PubMed ID: 16229763
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients.
    Baum HV; Franz U; Geiss HK
    Infection; 2000 Sep; 28(5):278-81. PubMed ID: 11073133
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Increasing fluoroquinolone low-sensitivity in enterotoxigenic Escherichia coli isolated from diarrhea of overseas travelers in Tokyo].
    Matsushita S; Kawamura M; Takahashi M; Yokoyama K; Konishi N; Hatakeyama K; Kai A; Morozumi S; Morita K; Watanabe N; Kanamori M; Kudoh Y
    Kansenshogaku Zasshi; 2001 Sep; 75(9):785-91. PubMed ID: 11605187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Investigation of In Vitro Susceptibility and Resistance Mechanisms in Skin Pathogens: Perspectives for Fluoroquinolone Therapy in Canine Pyoderma.
    Azzariti S; Bond R; Loeffler A; Zendri F; Timofte D; Chang YM; Pelligand L
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Zinc can counteract selection for ciprofloxacin resistance.
    Vos M; Sibleyras L; Lo LK; Hesse E; Gaze W; Klümper U
    FEMS Microbiol Lett; 2020 Feb; 367(3):. PubMed ID: 32105320
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
    Perea S; Hidalgo M; Arcediano A; Ramos MJ; Gomez C; Hornedo J; Lumbreras C; Folgueira D; Cortes-Funes H; Rodriguez-Noriega A
    J Antimicrob Chemother; 1999 Jul; 44(1):117-20. PubMed ID: 10459819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains.
    Sørum V; Øynes EL; Møller AS; Harms K; Samuelsen Ø; Podnecky NL; Johnsen PJ
    mBio; 2022 Aug; 13(4):e0044122. PubMed ID: 35862779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Global DNA Methylation Level among Ciprofloxacin-Resistant Clinical Isolates of Escherichia coli.
    Yugendran T; Harish BN
    J Clin Diagn Res; 2016 May; 10(5):DC27-30. PubMed ID: 27437217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of oral orbifloxacin on fecal coliforms in healthy cats: a pilot study.
    Harada K; Sasaki A; Shimizu T
    J Vet Med Sci; 2016 Jan; 78(1):83-9. PubMed ID: 26311787
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Occurrence of Escherichia coli non-susceptible to quinolones in faecal samples from fluoroquinolone-treated, contact and control pigs of different ages from 24 Swiss pig farms.
    Amsler M; Zurfluh K; Hartnack S; Sidler X; Stephan R; Kümmerlen D
    Porcine Health Manag; 2021 Apr; 7(1):29. PubMed ID: 33810820
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular typing of fluoroquinolone-resistant and fluoroquinolone-susceptible Escherichia coli isolated from blood of neutropenic cancer patients in a single center.
    Tascini C; Menichetti F; Bozza S; Fedele M; Preziosi R; Allegrucci M; Del Favero A; Micozzi A; Martino P; Bistoni F
    Clin Microbiol Infect; 1999 Aug; 5(8):457-461. PubMed ID: 11856289
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genomewide screening for novel genetic variations associated with ciprofloxacin resistance in Bacillus anthracis.
    Serizawa M; Sekizuka T; Okutani A; Banno S; Sata T; Inoue S; Kuroda M
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2787-92. PubMed ID: 20385868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Substantial Contribution of SmeDEF, SmeVWX, SmQnr, and Heat Shock Response to Fluoroquinolone Resistance in Clinical Isolates of
    Wu CJ; Lu HF; Lin YT; Zhang MS; Li LH; Yang TC
    Front Microbiol; 2019; 10():822. PubMed ID: 31057523
    [No Abstract]   [Full Text] [Related]  

  • 76. Systematically integrated metabonomic-proteomic studies of Escherichia coli under ciprofloxacin stress.
    Li W; Zhang S; Wang X; Yu J; Li Z; Lin W; Lin X
    J Proteomics; 2018 May; 179():61-70. PubMed ID: 29522880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative
    Kim Y; Kim B; Wie SH; Kim J; Ki M; Cho YK; Lim SK; Lee JS; Kwon KT; Lee H; Cheong HJ; Park DW; Ryu SY; Chung MH; Pai H
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33401660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transcriptome Profiling Reveals Interplay of Multifaceted Stress Response in
    Goswami M; Narayana Rao AVSS
    mSystems; 2018; 3(1):. PubMed ID: 29468195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emergence of antibiotic resistance from multinucleated bacterial filaments.
    Bos J; Zhang Q; Vyawahare S; Rogers E; Rosenberg SM; Austin RH
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):178-83. PubMed ID: 25492931
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative NanoUPLC-MS
    Cardoso MH; de Almeida KC; Cândido ES; Murad AM; Dias SC; Franco OL
    Sci Rep; 2017 Jun; 7(1):4197. PubMed ID: 28646205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.